Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello! Baby KJ is back home! Also, we discuss the questionable efficacy of ctDNA blood tests, see what Vinay Prasad has to say at NORD, and more.

After groundbreaking CRISPR therapy, a homecoming

From my colleague Jason Mast: KJ Muldoon, the first infant treated with a personalized gene-editing drug , has been discharged from the hospital for the first time in his life, the Children’s Hospital of Philadelphia announced Tuesday. After 307 days at CHOP, KJ was dressed in what early studies suggest are the world’s smallest and cutest graduation cap-and-gown before leaving.

It’s a promising sign for KJ, his family, and the therapy researchers built in just 6 mo

See Full Page